These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32118480)

  • 1. Differential Urinary Proteomic Analysis of Endometrial Cancer.
    Kacírová M; Bober P; Alexovič M; Tomková Z; Tkáčiková S; Talian I; Mederová L; Bérešová D; Tóth R; Andrašina I; Kožlejová Z; Kilík R; Divín R; Sabo J
    Physiol Res; 2019 Dec; 68(Suppl 4):S483-S490. PubMed ID: 32118480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
    Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
    Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered urinary profiles of endogenous steroids in postmenopausal women with adenocarcinoma endometrii.
    Bufa A; Bíró I; Poór V; Molnár G; Kovács KA; Felinger A; Jeges S; Kilár F; Gocze PM
    Gynecol Endocrinol; 2010 Jan; 26(1):10-5. PubMed ID: 19670000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and verifying endometrial carcinoma diagnostic biomarkers based on a urine metabolomic profiling study using UPLC-Q-TOF/MS.
    Shao X; Wang K; Liu X; Gu C; Zhang P; Xie J; Liu W; Sun L; Chen T; Li Y
    Clin Chim Acta; 2016 Dec; 463():200-206. PubMed ID: 27784637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
    Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
    Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.
    Galazis N; Pang YL; Galazi M; Haoula Z; Layfield R; Atiomo W
    Gynecol Endocrinol; 2013 Jul; 29(7):638-44. PubMed ID: 23527552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
    Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
    Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
    Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
    Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical squamous cells in the urine revealing endometrioid adenocarcinoma of the endometrium with squamous cell differentiation: a case report.
    Wang Y; Otis CN; Florence RR
    Diagn Cytopathol; 2015 Jan; 43(1):49-52. PubMed ID: 24535963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin.
    Isci Bostanci E; Ugras Dikmen A; Girgin G; Gungor T; Baydar T; Nuri Danisman A
    Int J Gynecol Cancer; 2017 May; 27(4):754-758. PubMed ID: 28383326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma.
    Teng Y; Ai Z; Wang Y; Wang J; Luo L
    J Obstet Gynaecol Res; 2013 Jan; 39(1):317-25. PubMed ID: 22889453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of the PTEN protein and matrix metalloproteinase-2 in endometrial cysts, endometrioid and clear cell ovarian cancer.
    Brucka A; Szyłło K
    Ginekol Pol; 2013 May; 84(5):344-51. PubMed ID: 23819399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
    Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
    Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of laparoscopic surgery versus laparotomy for patients with endometrioid endometrial cancer: experience from an institute in China.
    Lu Z; Yi X; Feng W; Ding J; Xu H; Zhou X; Hua K
    J Obstet Gynaecol Res; 2012 Jul; 38(7):1011-7. PubMed ID: 22487546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Li HW; Leung SW; Chan CS; Yu MM; Wong YF
    Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
    Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
    Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
    Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.